Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model

Figure 6

Gd concentrations in different brain areas of normal (a-c) and diabetic rats (d-f) 42 days after multiple injections of gadodiamide, gadopentetate dimeglumine, and gadoterate meglumine (mean ± SD).

(a)

(b)

(c)

(d)

(e)

(f)